Atlas FDA

LQN

13 FDA 510(k) clearances · Product code

182 daysmedian time to decision
300 days90th percentile
13clearances measured

FDA profile

Official device name
Latex Agglutination Assay, Rubella
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3510
Medical specialty
Microbiology
Flags
Third-party review eligible
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
RUBELLACOL (K031490)Immunostics Inc.,2003-07-16
COPALIS TORC TOTAL ANTIBODY ASSAY (K970931)Sienna Biotech, Inc.1997-04-24
COPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY ASSAYS (K961784)Sienna Biotech, Inc.1996-10-31
MUREX RUB-EX (K954920)Murex Diagnostics, Inc.1996-08-21
COLORSLIDER RUBELLA (K952544)Seradyn, Inc.1996-01-17
RUBALEX, MODIFICATION (K912391)Orion Corp.1992-05-04
RESUBMITTED MODIFIED RUBALEX (K901637)Orion Corp.1990-04-26
MODIFIED RUBAGEN (K896433)Biokit USA, Inc.1989-11-29
RUBAGEN (K893755)Biokit USA, Inc.1989-08-21
RUBALEX (REVISED VERSION) (K861881)Orion Corp.1986-06-04
RUBALEX (K852788)Orion Corp.1986-03-12
VIROGEN RUBELLA MICROTITER TEST (K844436)Armkel, LLC1985-05-21
VIROGEN RUBELLA SLIDE TEST (K844435)Armkel, LLC1985-05-20

Track LQN automatically

Every clearance here is in the API, with alerts when new ones post.